Abstract
Eosinophilic inflammation and airway remodeling are features of asthma. Eosinophil cationic protein (ECP) is released by activated eosinophils and transforming growth factor (TGF)-β1 has major functions in the fibrotic process. We therefore hypothesized that ECP stimulates TGF-β1 release by human lung fibroblasts. Fibroblasts in monolayer displayed a constitutive release of TGF-β1, which increased in presence of ECP (436 ± 60 vs. 365 ± 48 pg/ml at 48 h; P < 0.01). mRNA expression of TGF-β1 was almost twofold in ECP-stimulated fibroblasts. ECP in three-dimensional cultures stimulated both TGF-β1 release (180 ± 61 vs. 137 ± 54 pg/ml; P < 0.01) and fibroblast-mediated collagen gel contraction (28 vs. 39% of initial gel area at 48 h; P < 0.001). ECP stimulates TGF-β1-release by human lung fibroblasts, suggesting a potential mechanism for eosinophils in the fibrotic response. This may be an important mechanism by which ECP promotes remodeling of extra cellular matrix leading to airway fibrosis in asthmatics.
Similar content being viewed by others
References
Wilson, J. W., and T. L. Bamford. 2001. Assessing the evidence for remodelling of the airway in asthma. Pulm. Pharmacol. Ther. 14:229–247.
Venge, P., J. Bystrom, M. Carlson, L. Hakansson, M. Karawacjzyk, C. Peterson, L. Seveus, and A. Trulson. 1999. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin. Exp. Allergy 29:1172–1186.
Martin, L. B., H. Kita, K. M. Leiferman, and G. J. Gleich. 1996. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int. Arch. Allergy Immunol. 109:207–215.
Venge, P. 2004. Monitoring the allergic inflammation. Allergy 59:26–32.
Sime, P., G. Tremblay, Z. Xing, B. Sarnstrand, J. Gauldie. 1997. Asthma, A. Woolcock ed. Lippincott-Raven Publishers, Philadelphia, pp. 475–489.
Diegelmann, R. F., and M. C. Evans. 2004. Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 9:283–289.
Zagai U, C. M. Skold, A. Trulson, P. Venge, and J. Lundahl. 2004. The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. Clin. Exp. Immunol. 135:427–433.
Bell, E., B. Ivarsson, and C. Merrill. 1979. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. U.S.A. 76:1274–1278.
Grinnell, F. 1994. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124:401–404.
Adachi, Y., T. Mio, K. Takigawa, I. Striz, D. J. Romberger, J. R. Spurzem, and S. I. Rennard. 1998. Fibronectin production by cultured human lung fibroblasts in three-dimensional collagen gel culture. In Vitro Cell Dev. Biol. Anim. 34:203–210.
Ohga, E., T. Matsuse, S. Teramoto, and Y. Ouchi. 2000. Activin receptors are expressed on human lung fibroblast and activin A facilitates fibroblast-mediated collagen gel contraction. Life Sci. 66:1603–1613.
Mio, T., X. Liu, M. L. Toews, Y. Adachi, D. J. Romberger, J. R. Spurzem, and S. I. Rennard. 2001. Bradykinin augments fibroblast-mediated contraction of released collagen gels. Am. J. Physiol. Lung. Cell Mol. Physiol. 281:L164–L171.
Liu, X., T. Kohyama, H. Wang, Y. K. Zhu, F. Q. Wen, H. J. Kim, D. J. Romberger, and S. I. Rennard. 2002. Th2 cytokine regulation of type I collagen gel contraction mediated by human lung mesenchymal cells. Am. J. Physiol. Lung. Cell Mol. Physiol. 282:L1049–L1056.
Peterson, C. G., H. Jornvall, and P. Venge. 1988. Purification and characterization of eosinophil cationic protein from normal human eosinophils. Eur. J. Haematol. 40:415–423.
Elsdale, T., J. Bard. 1972. Collagen substrata for studies on cell behavior. J. Cell Biol. 54:626–637.
Zagai, U., K. Fredriksson, S. I. Rennard, J. Lundahl, and C. M. Skold. 2003. Platelets stimulate fibroblast-mediated contraction of collagen gels. Respir. Res. 4:13.
Abe, M., J. G. Harpel, C. N. Metz, I. Nunes, D. J. Loskutoff, and D. B. Rifkin. 1994. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216:276–284.
Haagmans, B. L., J. W. Hoogerbrugge, A. P. Themmen, and K. J. Teerds. 2003. Rat testicular germ cells and sertoli cells release different types of bioactive transforming growth factor beta in vitro. Reprod. Biol. Endocrinol. 1:3.
Mio, T., Y. Adachi, D. J. Romberger, R. F. Ertl, and S. I. Rennard. 1996. Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell Dev. Biol. Anim. 32:427–433.
Montgomery, D. C. 1991. Design and Analysis of Experiments. John Wiley & Sons, New York.
Daniel, W. W. 1995. Biostatistics: A Foundation for Analysis in the Health Sciences. John Wiley & Sons, New York.
Claeys, S., H. Van Hoecke, G. Holtappels, P. Gevaert, T. De Belder, B. Verhasselt, P. Van Cauwenberge, and C. Bachert. 2005. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin. Exp. Allergy 35:467–472.
Hernnas, J., B. Sarnstrand, P. Lindroth, C. G. Peterson, P. Venge, and A. Malmstrom. 1992. Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur. J. Cell Biol. 59:352–363.
Bartram, U., and C. P. Speer. 2004. The role of transforming growth factor beta in lung development and disease. Chest 125:754–765.
Chapman, H. A. 2004. Disorders of lung matrix remodeling. J. Clin. Invest. 113:148–57.
Kunz-Schughart, L. A., S. Wenninger, T. Neumeier, P. Seidl, and R. Knuechel. 2003. Three-dimensional tissue structure affects sensitivity of fibroblasts to TGF-beta 1. Am. J. Physiol. Cell Physiol. 284:C209–C219.
Gaissmaier, C., J. Fritz, T. Krackhardt, I. Flesch, W. K. Aicher, and N. Ashammakhi. 2005. Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials 26:1953–1960.
Fukamizu, H, and F. Grinnell. 1990. Spatial organization of extracellular matrix and fibroblast activity: effects of serum, transforming growth factor beta, and fibronectin. Exp. Cell Res. 190:276–282.
Lee, Y. M., S. S. Kim, H. A. Kim, Y. J. Suh, S. K. Lee, D. H. Nahm, and H. S. Park. 2003. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J. Korean Med. Sci. 18:97–102.
Buron, E., J. A. Garrote, E. Arranz, P. Oyaguez, J. L. Fernandez Calvo, and A. Blanco Quiros. 1999. Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome. Allergol. Immunopathol. (Madr). 27:11–17.
Acknowledgements
The authors would like to thank Professor Rolf Lewensohn at the Cancer Centrum Karolinska, for letting us use equipment for DNA analysis and Per Näsman at the Royal Institute of Technology, for assistance with statistical analysis. For the preparation and characterization of ECP the work of Lena Moberg and Agneta Trulson is greatly appreciated. The financial support from the Swedish Heart–Lung Foundation, Cancer and Allergy Foundation, Swedish Foundation for Health Care Science and Allergy Research, Hesselman Foundation, Boehringer-Ingelheim/Pfizer, the Swedish Research Council and Karolinska Institutet is greatly appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zagai, U., Dadfar, E., Lundahl, J. et al. Eosinophil Cationic Protein Stimulates TGF-β1 Release by Human Lung Fibroblasts In Vitro. Inflammation 30, 153–160 (2007). https://doi.org/10.1007/s10753-007-9032-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-007-9032-4